Crescendo Collective’s Post

Join me Thursday to learn how humm can support your practice in delivering the care pets need!

The countdown is on. We're excited to be heading back to Digital Pharma East September 9th - 12th in Philadelphia! Will you be joining us (and some of the biggest names in the business)? Save 15% on your pass at checkout with code Med15! https://lnkd.in/gJAh9nM3 #DPEast #DigitalPharmaEast #PharmaMarketing | Digital Pharma Series

Worried about getting the most out of all of the sessions ahead of you? If so, think about bringing your team to Future Pharma 2024!   You’ll maximize on the skills and strategies you gain, allowing the whole team to benefit from the expertise of industry-leading experts. After two days at Future Pharma, you’ll notice stronger team bonds and relationships, enhancing group collaboration and communication at the office going forward.   Check out our group options here: https://bit.ly/42TuOrc   Let us know who you're bringing to Future Pharma in the comments!   #futurepharma #pharmamarketing #patientcentric #pharma

Hear what draws Genentech’s Kimberly Barnholt back to DPHARM every year! “What I really appreciate about DPHARM is feeling connected to the broader ecosystem and learning about not only what’s out there, but how we can bring it back into our daily work.” Learn more about DPHARM: DPHARMconference.com #DPHARM2024 #ClinicalTrials #ClinicalInnovation #ClinicalResearch

"It's all about organizational health, and a culture is driven by the embrace of change." Terrence Terifay, Chief Commercial Officer, Azurity Pharmaceuticals At #DPEAST 2023, Terry, Paul Murasko, Head of Digital Innovation & Marketing Operations, Azurity Pharmaceuticals and Stephanie Butler (She/Her), Senior Conference Director, Fierce Life Sciences Events, discussed with attendees how Azurity Pharmaceuticals is using a data-driven omnichannel approach in their Go-to-market strategy.🌟 Learn more about how you can get tickets to this year's Digital Pharma East September 9-12, 2024 and attend engaging discussions to keep you informed and prepared to strategically address the exciting evolution of our industry ✅: https://ow.ly/B6PK50QxZgv #DigitalPharma #DigPharm #pharmamarketing #digitalmarketing #marketing #innovationinhealthcare #FiercePharma #PharmaEvents #fiercelifesciences #WeAreFierce

The right message in the right way to the right audience!

🎉 The Ontario Pharmaceutical Marketing Association has done it again! Kaidi Zhou, MSc and Julia Hatherell represented Metrix at the GM Spotlight event earlier this week. Thanks to the incredible panel and moderator (Colleen Coxson, Kenneth Custer, Paul Petrelli, Leandra Wells, PhD, MBA and Sangeeta Shah B.Sc.Phm). Here are some of our takeaways: ✈ The journey to the GM role... • There is not one single path. GMs come from diverse backgrounds and starting points, such as academia (2 science PhDs on the panel!) and agency. • You can always expect some imposter syndrome, but don’t let it deter you. Know that you deserve to be where you are in your journey. 🤝 As a GM... • Your job isn’t to be the smartest person in the room. Rather, it’s to ensure the right people are in each position and they are empowered to be at their best. • Ultimately, everything always comes down to the patients and seeing the impact we make in their lives. The in-person interaction with HCPs and hearing about their patients was mentioned as being one of the most rewarding parts of the job. #OPMA #Networking #MetrixNetworking #GMinPharma #PharmaMarketing

On this #WorldFirstAidDay, let's remember that timely help can save lives. At Novolilly Pharma, we believe in empowering individuals with the knowledge and tools to act swiftly in emergencies. Stay prepared, stay safe. #FirstAidMatters #NovolillyPharma #HealthForAll #LearnFirstAid #FirstAidSavesLives

In a stunning move, Clayton Dubilier & Rice (CD&R) is nearing a €15 billion acquisition of Sanofi's consumer health unit, Opella. This deal not only highlights CD&R's ambition to penetrate the lucrative consumer health market but also underscores Sanofi's strategic pivot towards innovative pharmaceuticals and vaccines. With brands like Doliprane under its wing, CD&R stands to leverage Opella's strong market presence while the French government ensures job security and local investment—a win for both the economy and stakeholders. As we witness this significant shift, it sparks a conversation about the future of healthcare consolidation and innovation. The rise of self-care and digital health solutions could redefine how we approach consumer health, making this acquisition one to watch closely. Will CD&R's operational efficiencies unlock Opella's full potential? Only time will tell!

Check out this 3-minute introductory video to the XPharma application 🔥 https://lnkd.in/dAPUrGdA